Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 381

1.

Development and Multiparametric Evaluation of Experimental Atherosclerosis in Rabbits.

Senders ML, Lobatto ME, Soler R, Lairez O, Pérez-Medina C, Calcagno C, Fayad ZA, Mulder WJM, Fay F.

Methods Mol Biol. 2018;1816:385-400. doi: 10.1007/978-1-4939-8597-5_30.

PMID:
29987836
2.

New methods to image unstable atherosclerotic plaques.

Andrews JPM, Fayad ZA, Dweck MR.

Atherosclerosis. 2018 May;272:118-128. doi: 10.1016/j.atherosclerosis.2018.03.021. Epub 2018 Mar 14. Review.

3.

Effect of varying computed tomography acquisition and reconstruction parameters on semi-automated clot volume quantification.

Kaufman AE, Pruzan AN, Hsu C, Ramachandran S, Jacobi A, Fayad ZA, Mani V.

World J Radiol. 2018 Mar 28;10(3):24-29. doi: 10.4329/wjr.v10.i3.24.

4.

Carotid Artery Remodeling Is Segment Specific: An In Vivo Study by Vessel Wall Magnetic Resonance Imaging.

Watase H, Sun J, Hippe DS, Balu N, Li F, Zhao X, Mani V, Fayad ZA, Fuster V, Hatsukami TS, Yuan C.

Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):927-934. doi: 10.1161/ATVBAHA.117.310296. Epub 2018 Feb 22.

PMID:
29472231
5.

Combined PET/DCE-MRI in a Rabbit Model of Atherosclerosis: Integrated Quantification of Plaque Inflammation, Permeability, and Burden During Treatment With a Leukotriene A4 Hydrolase Inhibitor.

Calcagno C, Lairez O, Hawkins J, Kerr SW, Dugas MS, Simpson T, Epskamp J, Robson PM, Eldib M, Bander I, K-Raman P, Ramachandran S, Pruzan A, Kaufman A, Mani V, Ehlgen A, Niessen HG, Broadwater J, Fayad ZA.

JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 2):291-301. doi: 10.1016/j.jcmg.2017.11.030.

PMID:
29413439
6.

PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis.

Senders ML, Que X, Cho YS, Yeang C, Groenen H, Fay F, Calcagno C, Meerwaldt AE, Green S, Miu P, Lobatto ME, Reiner T, Fayad ZA, Witztum JL, Mulder WJM, Pérez-Medina C, Tsimikas S.

J Am Coll Cardiol. 2018 Jan 23;71(3):321-335. doi: 10.1016/j.jacc.2017.11.036.

7.

High-Density Lipoprotein Nanobiologics for Precision Medicine.

Mulder WJM, van Leent MMT, Lameijer M, Fisher EA, Fayad ZA, Pérez-Medina C.

Acc Chem Res. 2018 Jan 16;51(1):127-137. doi: 10.1021/acs.accounts.7b00339. Epub 2017 Dec 27.

PMID:
29281244
8.

Social stress induces neurovascular pathology promoting depression.

Menard C, Pfau ML, Hodes GE, Kana V, Wang VX, Bouchard S, Takahashi A, Flanigan ME, Aleyasin H, LeClair KB, Janssen WG, Labonté B, Parise EM, Lorsch ZS, Golden SA, Heshmati M, Tamminga C, Turecki G, Campbell M, Fayad ZA, Tang CY, Merad M, Russo SJ.

Nat Neurosci. 2017 Dec;20(12):1752-1760. doi: 10.1038/s41593-017-0010-3. Epub 2017 Nov 13.

9.

Cardiovascular Immunotherapy and the Role of Imaging.

Zupančič E, Fayad ZA, Mulder WJM.

Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):e167-e171. doi: 10.1161/ATVBAHA.117.309227. Review. No abstract available.

PMID:
29070539
10.

Integrating nanomedicine and imaging.

Pérez-Medina C, Hak S, Reiner T, Fayad ZA, Nahrendorf M, Mulder WJM.

Philos Trans A Math Phys Eng Sci. 2017 Nov 28;375(2107). pii: 20170110. doi: 10.1098/rsta.2017.0110. Review.

PMID:
29038380
11.

Arterial Thrombus Stability: Does It Matter and Can We Detect It?

Gorog DA, Fayad ZA, Fuster V.

J Am Coll Cardiol. 2017 Oct 17;70(16):2036-2047. doi: 10.1016/j.jacc.2017.08.065. Review.

PMID:
29025561
12.

MR/PET Imaging of the Cardiovascular System.

Robson PM, Dey D, Newby DE, Berman D, Li D, Fayad ZA, Dweck MR.

JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt A):1165-1179. doi: 10.1016/j.jcmg.2017.07.008. Review.

13.

Unraveling Vascular Inflammation: From Immunology to Imaging.

Teague HL, Ahlman MA, Alavi A, Wagner DD, Lichtman AH, Nahrendorf M, Swirski FK, Nestle F, Gelfand JM, Kaplan MJ, Grinspoon S, Ridker PM, Newby DE, Tawakol A, Fayad ZA, Mehta NN.

J Am Coll Cardiol. 2017 Sep 12;70(11):1403-1412. doi: 10.1016/j.jacc.2017.07.750. Review.

PMID:
28882238
14.

Imaging: Perivascular fat - an unheralded informant of coronary inflammation.

Dweck MR, Fayad ZA.

Nat Rev Cardiol. 2017 Oct;14(10):573-574. doi: 10.1038/nrcardio.2017.127. Epub 2017 Aug 24. No abstract available.

PMID:
28836621
15.

Vessel wall characterization using quantitative MRI: what's in a number?

Coolen BF, Calcagno C, van Ooij P, Fayad ZA, Strijkers GJ, Nederveen AJ.

MAGMA. 2018 Feb;31(1):201-222. doi: 10.1007/s10334-017-0644-x. Epub 2017 Aug 14. Review.

16.

Reply to: "β-blocker treatment of vascular disease in cocaine addiction".

Bachi K, Mani V, Trivieri MG, Jeyachandran D, Fayad ZA, Goldstein RZ, Alia-Klein N.

Atherosclerosis. 2017 Sep;264:123-124. doi: 10.1016/j.atherosclerosis.2017.07.012. Epub 2017 Jul 15. No abstract available.

PMID:
28735812
17.

A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis.

Alaarg A, Senders ML, Varela-Moreira A, Pérez-Medina C, Zhao Y, Tang J, Fay F, Reiner T, Fayad ZA, Hennink WE, Metselaar JM, Mulder WJM, Storm G.

J Control Release. 2017 Sep 28;262:47-57. doi: 10.1016/j.jconrel.2017.07.013. Epub 2017 Jul 9.

18.

Plaque microvascularization and permeability: Key players in atherogenesis and plaque rupture.

Calcagno C, Fayad ZA, Raggi P.

Atherosclerosis. 2017 Aug;263:320-321. doi: 10.1016/j.atherosclerosis.2017.06.915. Epub 2017 Jun 21. No abstract available.

PMID:
28673479
19.

3D black blood MR angiography of the carotid arteries. A simple sequence for plaque hemorrhage and stenosis evaluation.

Sigovan M, Bidet C, Bros S, Boussel L, Mechtouff L, Robson PM, Fayad ZA, Millon A, Douek P.

Magn Reson Imaging. 2017 Oct;42:95-100. doi: 10.1016/j.mri.2017.06.004. Epub 2017 Jun 16.

PMID:
28629953
20.

Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.

Dweck MR, Abgral R, Trivieri MG, Robson PM, Karakatsanis N, Mani V, Palmisano A, Miller MA, Lala A, Chang HL, Sanz J, Contreras J, Narula J, Fuster V, Padilla M, Fayad ZA, Kovacic JC.

JACC Cardiovasc Imaging. 2018 Jan;11(1):94-107. doi: 10.1016/j.jcmg.2017.02.021. Epub 2017 Jun 14.

21.

Applying nanomedicine in maladaptive inflammation and angiogenesis.

Alaarg A, Pérez-Medina C, Metselaar JM, Nahrendorf M, Fayad ZA, Storm G, Mulder WJM.

Adv Drug Deliv Rev. 2017 Sep 15;119:143-158. doi: 10.1016/j.addr.2017.05.009. Epub 2017 May 12. Review.

PMID:
28506745
22.

Intraplaque and Cellular Distribution of Dextran-Coated Iron Oxide Fluorescently Labeled Nanoparticles: Insights Into Atherothrombosis and Plaque Rupture.

Calcagno C, Fayad ZA.

Circ Cardiovasc Imaging. 2017 May;10(5). pii: e006533. doi: 10.1161/CIRCIMAGING.117.006533. No abstract available.

23.

Multitarget Vulnerable Plaque Imaging.

Dweck MR, Fayad ZA.

Circ Cardiovasc Imaging. 2017 May;10(5). pii: e006491. doi: 10.1161/CIRCIMAGING.117.006491. No abstract available.

24.

Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis.

Beldman TJ, Senders ML, Alaarg A, Pérez-Medina C, Tang J, Zhao Y, Fay F, Deichmöller J, Born B, Desclos E, van der Wel NN, Hoebe RA, Kohen F, Kartvelishvily E, Neeman M, Reiner T, Calcagno C, Fayad ZA, de Winther MPJ, Lutgens E, Mulder WJM, Kluza E.

ACS Nano. 2017 Jun 27;11(6):5785-5799. doi: 10.1021/acsnano.7b01385. Epub 2017 May 15.

25.

Rationale and Design of Family-Based Approach in a Minority Community Integrating Systems-Biology for Promotion of Health (FAMILIA).

Bansilal S, Vedanthan R, Kovacic JC, Soto AV, Latina J, Björkegren JLM, Jaslow R, Santana M, Sartori S, Giannarelli C, Mani V, Hajjar R, Schadt E, Kasarskis A, Fayad ZA, Fuster V.

Am Heart J. 2017 May;187:170-181. doi: 10.1016/j.ahj.2017.02.020. Epub 2017 Feb 22.

PMID:
28454800
26.

Vascular disease in cocaine addiction.

Bachi K, Mani V, Jeyachandran D, Fayad ZA, Goldstein RZ, Alia-Klein N.

Atherosclerosis. 2017 Jul;262:154-162. doi: 10.1016/j.atherosclerosis.2017.03.019. Epub 2017 Mar 14. Review.

27.

Investigating the Cellular Specificity in Tumors of a Surface-Converting Nanoparticle by Multimodal Imaging.

Fay F, Hansen L, Hectors SJCG, Sanchez-Gaytan BL, Zhao Y, Tang J, Munitz J, Alaarg A, Braza MS, Gianella A, Aaronson SA, Reiner T, Kjems J, Langer R, Hoeben FJM, Janssen HM, Calcagno C, Strijkers GJ, Fayad ZA, Pérez-Medina C, Mulder WJM.

Bioconjug Chem. 2017 May 17;28(5):1413-1421. doi: 10.1021/acs.bioconjchem.7b00086. Epub 2017 May 5.

28.

Feasibility of imaging superficial palmar arch using micro-ultrasound, 7T and 3T magnetic resonance imaging.

Pruzan AN, Kaufman AE, Calcagno C, Zhou Y, Fayad ZA, Mani V.

World J Radiol. 2017 Feb 28;9(2):79-84. doi: 10.4329/wjr.v9.i2.79.

29.

Molecular Imaging of Atheroma: Deciphering How and When to Use 18F-Sodium Fluoride and 18F-Fluorodeoxyglucose.

Tawakol A, Osborne MT, Fayad ZA.

Circ Cardiovasc Imaging. 2017 Mar;10(3). pii: e006183. doi: 10.1161/CIRCIMAGING.117.006183. No abstract available.

30.

Real-Time Monitoring of Nanoparticle Formation by FRET Imaging.

Sanchez-Gaytan BL, Fay F, Hak S, Alaarg A, Fayad ZA, Pérez-Medina C, Mulder WJ, Zhao Y.

Angew Chem Int Ed Engl. 2017 Mar 6;56(11):2923-2926. doi: 10.1002/anie.201611288. Epub 2017 Jan 23.

31.

Coronary Artery PET/MR Imaging: Feasibility, Limitations, and Solutions.

Robson PM, Dweck MR, Trivieri MG, Abgral R, Karakatsanis NA, Contreras J, Gidwani U, Narula JP, Fuster V, Kovacic JC, Fayad ZA.

JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt A):1103-1112. doi: 10.1016/j.jcmg.2016.09.029. Epub 2017 Jan 18.

PMID:
28109921
32.

Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease.

Keliher EJ, Ye YX, Wojtkiewicz GR, Aguirre AD, Tricot B, Senders ML, Groenen H, Fay F, Perez-Medina C, Calcagno C, Carlucci G, Reiner T, Sun Y, Courties G, Iwamoto Y, Kim HY, Wang C, Chen JW, Swirski FK, Wey HY, Hooker J, Fayad ZA, Mulder WJ, Weissleder R, Nahrendorf M.

Nat Commun. 2017 Jan 16;8:14064. doi: 10.1038/ncomms14064.

33.

Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study.

Tawakol A, Ishai A, Takx RA, Figueroa AL, Ali A, Kaiser Y, Truong QA, Solomon CJ, Calcagno C, Mani V, Tang CY, Mulder WJ, Murrough JW, Hoffmann U, Nahrendorf M, Shin LM, Fayad ZA, Pitman RK.

Lancet. 2017 Feb 25;389(10071):834-845. doi: 10.1016/S0140-6736(16)31714-7. Epub 2017 Jan 12. Erratum in: Lancet. 2017 Feb 25;389(10071):804. Lancet. 2017 Feb 25;389(10071):804.

PMID:
28088338
34.

18F-Sodium Fluoride PET/MR for the Assessment of Cardiac Amyloidosis.

Trivieri MG, Dweck MR, Abgral R, Robson PM, Karakatsanis NA, Lala A, Contreras J, Sahni G, Gopalan R, Gorevic P, Fuster V, Narula J, Fayad ZA.

J Am Coll Cardiol. 2016 Dec 20;68(24):2712-2714. doi: 10.1016/j.jacc.2016.09.953. No abstract available.

35.

Coronary Plaque Morphology and the Anti-Inflammatory Impact of Atorvastatin: A Multicenter 18F-Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Study.

Singh P, Emami H, Subramanian S, Maurovich-Horvat P, Marincheva-Savcheva G, Medina HM, Abdelbaky A, Alon A, Shankar SS, Rudd JH, Fayad ZA, Hoffmann U, Tawakol A.

Circ Cardiovasc Imaging. 2016 Dec;9(12). pii: e004195.

36.

Imaging the Permeable Endothelium: Predicting Plaque Rupture in Atherosclerotic Rabbits.

Calcagno C, Fayad ZA.

Circ Cardiovasc Imaging. 2016 Dec;9(12). pii: e005955. No abstract available.

37.

Imaging-guided revival of nanomedicine?

Senders ML, Fayad ZA, Reiner T, Mulder WJ, Pérez-Medina C.

Nanomedicine (Lond). 2017 Jan;12(2):89-90. Epub 2016 Nov 23. No abstract available.

38.

Computed Tomography and Cardiac Magnetic Resonance in Ischemic Heart Disease.

Dweck MR, Williams MC, Moss AJ, Newby DE, Fayad ZA.

J Am Coll Cardiol. 2016 Nov 15;68(20):2201-2216. doi: 10.1016/j.jacc.2016.08.047. Review.

39.

Cap inflammation leads to higher plaque cap strain and lower cap stress: An MRI-PET/CT-based FSI modeling approach.

Tang D, Yang C, Huang S, Mani V, Zheng J, Woodard PK, Robson P, Teng Z, Dweck M, Fayad ZA.

J Biomech. 2017 Jan 4;50:121-129. doi: 10.1016/j.jbiomech.2016.11.011. Epub 2016 Nov 11.

40.

The future of imaging in cardiovascular disease intervention trials: 2017 and beyond.

Doris MK, Dweck MR, Fayad ZA.

Curr Opin Lipidol. 2016 Dec;27(6):605-614. Review.

41.

Immune cell screening of a nanoparticle library improves atherosclerosis therapy.

Tang J, Baxter S, Menon A, Alaarg A, Sanchez-Gaytan BL, Fay F, Zhao Y, Ouimet M, Braza MS, Longo VA, Abdel-Atti D, Duivenvoorden R, Calcagno C, Storm G, Tsimikas S, Moore KJ, Swirski FK, Nahrendorf M, Fisher EA, Pérez-Medina C, Fayad ZA, Reiner T, Mulder WJ.

Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6731-E6740. Epub 2016 Oct 17.

42.

Short-term changes in arterial inflammation predict long-term changes in atherosclerosis progression.

Joseph P, Ishai A, Mani V, Kallend D, Rudd JH, Fayad ZA, Tawakol A.

Eur J Nucl Med Mol Imaging. 2017 Jan;44(1):141-150. Epub 2016 Oct 13.

PMID:
27738728
43.

Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance.

Choudhury RP, Birks JS, Mani V, Biasiolli L, Robson MD, L'Allier PL, Gingras MA, Alie N, McLaughlin MA, Basson CT, Schecter AD, Svensson EC, Zhang Y, Yates D, Tardif JC, Fayad ZA.

J Am Coll Cardiol. 2016 Oct 18;68(16):1769-1780. doi: 10.1016/j.jacc.2016.07.768.

44.

Optimization and Reproducibility of Aortic Valve 18F-Fluoride Positron Emission Tomography in Patients With Aortic Stenosis.

Pawade TA, Cartlidge TR, Jenkins WS, Adamson PD, Robson P, Lucatelli C, Van Beek EJ, Prendergast B, Denison AR, Forsyth L, Rudd JH, Fayad ZA, Fletcher A, Tuck S, Newby DE, Dweck MR.

Circ Cardiovasc Imaging. 2016 Oct;9(10). pii: e005131.

45.

Conformational Changes in High-Density Lipoprotein Nanoparticles Induced by High Payloads of Paramagnetic Lipids.

Ramos-Cabrer P, Fay F, Sanchez-Gaytan BL, Tang J, Castillo J, Fayad ZA, Mulder WJ.

ACS Omega. 2016 Sep 30;1(3):470-475. Epub 2016 Sep 26.

46.

Optimization of yttrium-90 PET for simultaneous PET/MR imaging: A phantom study.

Eldib M, Oesingmann N, Faul DD, Kostakoglu L, Knešaurek K, Fayad ZA.

Med Phys. 2016 Aug;43(8):4768. doi: 10.1118/1.4958958.

PMID:
27487894
47.

Oral AGE restriction ameliorates insulin resistance in obese individuals with the metabolic syndrome: a randomised controlled trial.

Vlassara H, Cai W, Tripp E, Pyzik R, Yee K, Goldberg L, Tansman L, Chen X, Mani V, Fayad ZA, Nadkarni GN, Striker GE, He JC, Uribarri J.

Diabetologia. 2016 Oct;59(10):2181-92. doi: 10.1007/s00125-016-4053-x. Epub 2016 Jul 29.

48.

Noninvasive Molecular Imaging of Disease Activity in Atherosclerosis.

Dweck MR, Aikawa E, Newby DE, Tarkin JM, Rudd JH, Narula J, Fayad ZA.

Circ Res. 2016 Jul 8;119(2):330-40. doi: 10.1161/CIRCRESAHA.116.307971. Review.

49.

The Role of Imaging in Aortic Valve Disease.

Everett RJ, Newby DE, Jabbour A, Fayad ZA, Dweck MR.

Curr Cardiovasc Imaging Rep. 2016;9:21. Epub 2016 Jun 7. Review.

50.

Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease.

Abgral R, Dweck MR, Trivieri MG, Robson PM, Karakatsanis N, Mani V, Padilla M, Miller M, Lala A, Sanz J, Narula J, Fuster V, Contreras J, Kovacic JC, Fayad ZA.

JACC Cardiovasc Imaging. 2017 May;10(5):594-597. doi: 10.1016/j.jcmg.2016.02.029. Epub 2016 Jun 29. No abstract available.

Supplemental Content

Loading ...
Support Center